0001104659-21-082242.txt : 20210617 0001104659-21-082242.hdr.sgml : 20210617 20210617060156 ACCESSION NUMBER: 0001104659-21-082242 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 EFFECTIVENESS DATE: 20210617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DarioHealth Corp. CENTRAL INDEX KEY: 0001533998 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 452973162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-403224 FILM NUMBER: 211023290 BUSINESS ADDRESS: STREET 1: 142 W 57TH ST., 8TH FL. CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646.665.4667 MAIL ADDRESS: STREET 1: 142 W 57TH ST., 8TH FL. CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: LabStyle Innovations Corp. DATE OF NAME CHANGE: 20111101 D 1 primary_doc.xml X0708 D LIVE 0001533998 DarioHealth Corp. 142 W. 57TH ST., 8TH FLOOR NEW YORK NY NEW YORK 10019 (646) 665-4667 DELAWARE Labstyle Innovations Corp. LabStyle Innovations Corp. Corporation true Erez Raphael 142 W. 57th St., 8th Floor New York NY NEW YORK 10019 Executive Officer Director Zvi Ben-David 142 W. 57th St., 8th Floor New York NY NEW YORK 10019 Executive Officer Dror Bacher 142 W. 57th St., 8th Floor New York NY NEW YORK 10019 Executive Officer Richard Anderson 142 W. 57th St., 8th Floor New York NY NEW YORK 10019 Executive Officer Yoav Shaked 142 W. 57th St., 8th Floor New York NY NEW YORK 10019 Director Adam Stern 142 W. 57th St., 8th Floor New York NY NEW YORK 10019 Director Dennis Matheis 142 W. 57th St., 8th Floor New York NY NEW YORK 10019 Director Hila Karah 142 W. 57th St., 8th Floor New York NY NEW YORK 10019 Director Dennis M. McGrath 142 W. 57th St., 8th Floor New York NY NEW YORK 10019 Director Richard B Stone 142 W. 57th St., 8th Floor New York NY NEW YORK 10019 Director Biotechnology Decline to Disclose 06b false 2021-06-07 false true true 0 24000000 24000000 0 Total Amount Sold includes $2,750,000 of shares of Common Stock held back to secure indemnification obligations and $5,000,000 of shares of Common Stock issuable based on the earn-out provisions of the Issuer's May 15, 2021 Merger Agreement. false 74 0 0 0 false DarioHealth Corp. /s/ Zvi Ben-David Zvi Ben-David Chief Financial Officer 2021-06-16